Haemonetics Stock Price Prediction

HAE Stock  USD 87.47  0.42  0.48%   
The relative strength index (RSI) of Haemonetics' share price is above 70 at the present time. This usually indicates that the stock is becoming overbought or overvalued. The idea behind Relative Strength Index (RSI) is that it helps to track how fast people are buying or selling Haemonetics, making its price go up or down.

Oversold Vs Overbought

72

 
Oversold
 
Overbought
The successful prediction of Haemonetics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Haemonetics and does not consider all of the tangible or intangible factors available from Haemonetics' fundamental data. We analyze noise-free headlines and recent hype associated with Haemonetics, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Haemonetics' stock price prediction:
Quarterly Earnings Growth
0.375
EPS Estimate Next Quarter
1.23
EPS Estimate Current Year
3.96
EPS Estimate Next Year
4.4
Wall Street Target Price
110.8
Using Haemonetics hype-based prediction, you can estimate the value of Haemonetics from the perspective of Haemonetics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Haemonetics to buy its stock at a price that has no basis in reality. In that case, they are not buying Haemonetics because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Haemonetics after-hype prediction price

    
  USD 86.89  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Haemonetics Basic Forecasting Models to cross-verify your projections.
For information on how to trade Haemonetics Stock refer to our How to Trade Haemonetics Stock guide.
Intrinsic
Valuation
LowRealHigh
86.8489.0791.30
Details
Naive
Forecast
LowNextHigh
78.0480.2682.49
Details
10 Analysts
Consensus
LowTargetHigh
97.63107.29119.09
Details
Earnings
Estimates (0)
LowProjected EPSHigh
1.121.181.21
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Haemonetics. Your research has to be compared to or analyzed against Haemonetics' peers to derive any actionable benefits. When done correctly, Haemonetics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Haemonetics.

Haemonetics After-Hype Price Prediction Density Analysis

As far as predicting the price of Haemonetics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Haemonetics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Haemonetics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Haemonetics Estimiated After-Hype Price Volatility

In the context of predicting Haemonetics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Haemonetics' historical news coverage. Haemonetics' after-hype downside and upside margins for the prediction period are 84.66 and 89.12, respectively. We have considered Haemonetics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
87.47
86.89
After-hype Price
89.12
Upside
Haemonetics is very steady at this time. Analysis and calculation of next after-hype price of Haemonetics is based on 3 months time horizon.

Haemonetics Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Haemonetics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Haemonetics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Haemonetics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.27 
2.23
  0.58 
  0.82 
13 Events / Month
10 Events / Month
In about 13 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
87.47
86.89
0.66 
103.72  
Notes

Haemonetics Hype Timeline

On the 30th of November Haemonetics is traded for 87.47. The entity has historical hype elasticity of -0.58, and average elasticity to hype of competition of -0.82. Haemonetics is forecasted to decline in value after the next headline, with the price expected to drop to 86.89. The average volatility of media hype impact on the company price is about 103.72%. The price depreciation on the next news is expected to be -0.66%, whereas the daily expected return is currently at 0.27%. The volatility of related hype on Haemonetics is about 73.0%, with the expected price after the next announcement by competition of 86.65. About 99.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 1.6. Haemonetics had not issued any dividends in recent years. The entity had 2:1 split on the 3rd of December 2012. Considering the 90-day investment horizon the next forecasted press release will be in about 13 days.
Check out Haemonetics Basic Forecasting Models to cross-verify your projections.
For information on how to trade Haemonetics Stock refer to our How to Trade Haemonetics Stock guide.

Haemonetics Related Hype Analysis

Having access to credible news sources related to Haemonetics' direct competition is more important than ever and may enhance your ability to predict Haemonetics' future price movements. Getting to know how Haemonetics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Haemonetics may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
MMSIMerit Medical Systems 0.25 9 per month 0.86 (0.01) 2.07 (1.23) 6.42 
ANGOAngioDynamics 0.02 13 per month 0.00 (0.05) 3.71 (4.03) 18.73 
ATRAptarGroup 0.48 10 per month 0.88  0.07  1.47 (1.37) 7.86 
NVSTEnvista Holdings Corp(1.03)7 per month 1.67  0.08  3.96 (2.68) 13.77 
HOLXHologic(0.82)12 per month 0.00 (0.12) 1.81 (1.79) 8.14 
ICUIICU Medical(18.49)10 per month 1.74 (0.07) 2.77 (2.50) 10.44 
COOThe Cooper Companies, 1.50 10 per month 0.84  0.02  1.53 (1.64) 13.98 
TFXTeleflex Incorporated(2.73)10 per month 0.00 (0.21) 1.71 (1.92) 17.00 
WSTWest Pharmaceutical Services(23.40)10 per month 2.04  0.01  4.50 (3.02) 22.42 
ALCAlcon AG(0.73)9 per month 0.00 (0.22) 1.69 (2.03) 8.43 
RMDResMed Inc 2.06 9 per month 1.61 (0.05) 2.08 (2.59) 11.88 
AKYAAkoya Biosciences 0.03 7 per month 0.00 (0.04) 8.59 (4.96) 40.94 
ATRCAtriCure 0.19 9 per month 1.37  0.14  4.67 (3.12) 23.09 
ATRIATRION(0.10)7 per month 0.00 (0.16) 0.94 (1.35) 6.29 

Haemonetics Additional Predictive Modules

Most predictive techniques to examine Haemonetics price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Haemonetics using various technical indicators. When you analyze Haemonetics charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Haemonetics Predictive Indicators

The successful prediction of Haemonetics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Haemonetics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Haemonetics based on analysis of Haemonetics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Haemonetics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Haemonetics's related companies.
 2023 2024 (projected)
Dividend Yield0.0110.00976
Price To Sales Ratio3.314.27

Story Coverage note for Haemonetics

The number of cover stories for Haemonetics depends on current market conditions and Haemonetics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Haemonetics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Haemonetics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Haemonetics Short Properties

Haemonetics' future price predictability will typically decrease when Haemonetics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Haemonetics often depends not only on the future outlook of the potential Haemonetics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Haemonetics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding51.4 M
Cash And Short Term Investments178.8 M

Complementary Tools for Haemonetics Stock analysis

When running Haemonetics' price analysis, check to measure Haemonetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Haemonetics is operating at the current time. Most of Haemonetics' value examination focuses on studying past and present price action to predict the probability of Haemonetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Haemonetics' price. Additionally, you may evaluate how the addition of Haemonetics to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Stocks Directory
Find actively traded stocks across global markets